Search Results - "Fallai C"

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

Authors: Bourhis J Overgaard J Audry H et al.

Source: Lancet. 9/2/2006, Vol. 368 Issue 9538, p843-854. 12p.

Fricke gel-layer dosimetry in high dose-rate brachytherapy

Authors: Carrara, M. Fallai, C. Gambarini, G. et al.

Source: Applied Radiation & Isotopes. Apr2010, Vol. 68 Issue 4/5, p722-725. 4p.

Subjects: Radiation dosimetry, Radiation doses, Radioisotope brachytherapy, Imaging phantoms, Neutron sources, Dosimeters, Thermoluminescence dosimetry

727 poster SINGLE FRACTION HDR BRACHYTHERAPY AS ANTICIPATED BOOST IN LOCALIZED PROSTATE CANCER

Authors: Cerrotta, A. Fallai, C. Carrara, M. et al.

Source: Radiotherapy & Oncology. May2011 Supplement 1, Vol. 99, pS288-S289. 0p.

Beneficial role of a functional P53 status in locoregionally advanced oropharyngeal carcinoma treated with radiotherapy or radio-chemotherapy

Authors: Fallai, C. Licitra, L. Perrone, F. et al.

Source: Radiotherapy & Oncology. Feb2007 Supplement 1, Vol. 82, pS49-S49. 1p.

Prognostic Value of P53 in HPV Negative Oropharyngeal Carcinoma Treated with Primary Radiotherapy or Radio-chemotherapy

Authors: Fallai, C. Licitra, L. Perrone, F. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2008 Supplement, Vol. 72 Issue s1, pS418-S419. 0p.

Loco-Regionally Advanced Oropharynx Carcinoma Treated With Radiotherapy or Radio-Chemotherapy: Prognostic Value of P53

Authors: Fallai, C. Licitra, L. Perrone, F. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Nov2007 Supplement, Vol. 69 Issue 3, pS448-S448. 1p.

Italian version of the M.D. Anderson Symptom Inventory--Head and Neck Module: linguistic validation.

Authors: Greco, A. Orlandi, E. Mirabile, A. et al.

Source: Supportive Care in Cancer. Dec2015, Vol. 23 Issue 12, p3465-3472. 8p.

LOCALLY ADVANCED NASAL CAVITY AND ETHMOID CARCINOMA: INDUCTION CHEMOTHERAPY FOLLOWED BY MULTIMODAL TREATMENT IN A MONOINSTITUTIONAL SERIES OF PATIENTS

Authors: Bossi, p. Locati, D. Fallai, C. et al.

Source: Radiotherapy & Oncology. Feb2011 Supplement 1, Vol. 98, pS9-S9. 1p.

Temperature dependence of a Ce3+ doped SiO2 radioluminescent dosimeter for in vivo dose measurements in HDR brachytherapy.

Authors: Carrara, M. Tenconi, C. Rossi, G. et al.

Source: Radiation Measurements. Dec2014, Vol. 71, p324-328. 5p.

Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.

Authors: Bossi, P. Orlandi, E. Miceli, R. et al.

Source: Annals of Oncology. Mar2014, Vol. 25 Issue 3, p694-699. 6p.

Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial.

Authors: Bossi, P. Lo Vullo, S. Guzzo, M. et al.

Source: Annals of Oncology. Feb2014, Vol. 25 Issue 2, p462-466. 5p. 1 Chart, 3 Graphs.

Solid state TL detectors for in vivo dosimetry in brachytherapy

Authors: Gambarini, G. Borroni, M. Grisotto, S. et al.

Source: Applied Radiation & Isotopes. Dec2012 Supplement, Vol. 71, p48-51. 4p.

Fricke gel dosimetric catheters in high dose rate brachytherapy. In phantom dose distribution measurements of a 5 catheter implant

Authors: Carrara, M. Gambarini, G. Borroni, M. et al.

Source: Radiation Measurements. Dec2011, Vol. 46 Issue 12, p1924-1927. 4p.

Docetaxel, cisplatin and 5-fluorouracil-based induction chemotherapy followed by intensity-modulated radiotherapy concurrent with cisplatin in locally advanced EBV-related nasopharyngeal cancer.

Authors: Bossi, P. Orlandi, E. Bergamini, C. et al.

Source: Annals of Oncology. Nov2011, Vol. 22 Issue 11, p2495-2500. 6p. 3 Charts, 1 Graph.

PO-1798: Quality of radiotherapy treatment plans for locally advanced sinonasal tumors in a phase II trial.

Authors: Vischioni, B. Mirandola, A. Bonora, M. et al.

Source: Radiotherapy & Oncology. 2020 Supplement 1, Vol. 152, pS1003-S1004. 2p.

PD-0545: Validation of a predictive model for salivary dysfunction during chemo-IMRT for head-neck cancer.

Authors: Cavallo, A. Rancati, T. Iacovelli, N.A. et al.

Source: Radiotherapy & Oncology. 2020 Supplement 1, Vol. 152, pS303-S304. 2p.

PH-0043: Age related toxicity and outcome in oropharyngeal and nasoparyngeal cancer patients.

Authors: IvaldI, E. Infante, G. Facchinetti, N. et al.

Source: Radiotherapy & Oncology. 2020 Supplement 1, Vol. 152, pS13-S14. 2p.

Detection of contaminating tumor cells by RT-PCR in breast cancer patients.

Authors: Vannucchi, A M Glinz, S Bosi, A et al.

Source: Bone Marrow Transplantation. 7/15/99, Vol. 24 Issue 2, p228. 2p.

Characterisation of a Fricke gel compound adopted to produce dosimetric catheters for in vivo dose measurements in HDR brachytherapy

Authors: Carrara, M. Gambarini, G. Borroni, M. et al.

Source: Nuclear Instruments & Methods in Physics Research Section A. Oct2011, Vol. 652 Issue 1, p888-890. 3p.

COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy.

Authors: Jereczek-Fossa, B.A. Palazzi, M.F. Soatti, C.P. et al.

Source: Clinical Oncology. Jul2020, Vol. 32 Issue 7, pe160-e161. 2p.